Onchocerciasis-Associated Epilepsy, an Explorative Case-control Study
NCT05868551 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2023-05-22
Summary
This is an exploratory case control study with the aim to compare the Onchocerca volvulus virome between persons with onchocerciasis-associated epilepsy (OAE) and persons with onchocerciasis but without epilepsy.
The main question we want to address is: Is there a virus contained in the O. volulus worm that may have a pathogenic role in causing OAE.
In Maridi County, South Sudan, 20 persons with OAE with onchocerciasis nodules, and 20 age- and village-matched controls without OAE will be enrolled in a nodulectomy study.The adult O. volvulus worms will be extracted from the nodules and a viral metagenomic study of the worms. The O. volvulus virome of persons with and without OAE will be compared.
Conditions
- Onchocercal Subcutaneous Nodule
- Epilepsy
- Virus
Interventions
- PROCEDURE
-
nodulectomy
incision in an onchocerciasis nodule to extract adult worms
Sponsors & Collaborators
-
Amref Health Africa
collaborator OTHER -
Universiteit Antwerpen
lead OTHER
Principal Investigators
-
Robert Colebunders, MD · Universiteit Antwerpen
Eligibility
- Min Age
- 12 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2024-07-01
- Completion
- 2024-12-31
Countries
- South Sudan
Study Locations
More Related Trials
-
Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
NCT00001912 ·Status: COMPLETED
-
Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana
NCT00463931 ·Status: COMPLETED
-
Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia
NCT01905436 ·Status: COMPLETED
-
People Presenting With Neurocysticercosis in North America
NCT02233855 ·Status: TERMINATED
-
Research for Elim of Filariasis
NCT00145223 ·Status: COMPLETED
-
Safety and Efficacy of IDA for Onchocerciasis
NCT04188301 ·Status: COMPLETED ·Phase: PHASE2
-
IVM Alone vs ALB + IVM Against Onchocerciasis
NCT03238131 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana
NCT02078024 ·Status: COMPLETED ·Phase: PHASE3
-
Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)
NCT02032043 ·Status: COMPLETED
-
Treatment of Patients With Active Neurocysticercosis in Eastern Africa
NCT03834337 ·Status: COMPLETED
-
Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
NCT04035174 ·Status: WITHDRAWN ·Phase: NA
-
EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso
NCT03095339 ·Status: COMPLETED ·Phase: NA
-
Research for Elimination of Lymphatic Filariasis (ICIDR)
NCT00406627 ·Status: COMPLETED
-
Spontaneous Antigenemia in Loiasis
NCT04258670 ·Status: UNKNOWN
-
Ocular Changes After Ivermectin - (DOLF IVM/Oncho)
NCT03517462 ·Status: COMPLETED ·Phase: NA
-
Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?
NCT02612896 ·Status: COMPLETED ·Phase: NA
-
Schistosoma Mansoni Morbidity in Children Aged 1-5 Years
NCT01901484 ·Status: COMPLETED ·Phase: PHASE2
-
Urinary Schistosomiasis Infection
NCT00138450 ·Status: COMPLETED
-
The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania
NCT03851419 ·Status: COMPLETED
-
Rift Valley Fever in Kenya
NCT00287014 ·Status: COMPLETED
-
Research for Angiostrongylus Cantonensis and Costaricensis in French West Indies and French Guiana
NCT03378882 ·Status: UNKNOWN
-
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda
NCT00215267 ·Status: COMPLETED ·Phase: NA
-
Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination
NCT06350851 ·Status: RECRUITING ·Phase: NA
-
Parasitological Evaluation of Fascioliasis in Clinically Suspected Patients .
NCT03869788 ·Status: UNKNOWN
-
Effect of Albendazole Dose on Clearance of Filarial Worms
NCT00339417 ·Status: COMPLETED ·Phase: PHASE2